Skip to main content

Table 1 Summary of case-control populations used in this study

From: Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection

  FTICR-MS discovery MRM validation
  Genomics Collaborative Seracare 1 Osaka Chiba Seracare 2
  CRC Control CRC Control CRC Control CRC Control CRC Control
Total 40 50 26 25 46 35 40 40 70 70
Male N 19 24 17 16 27 - 19 24 44 41
Male age 59 (30-78) 56 (30-78) 62 (46-80) 51 (35-70) 63 (28-90) - 68 (45-91) 48 (36-69) 67 (39-87) 63 (32-82)
Male BMI 20.9 ± 3.8 25.0 ± 0.9 24.3 ± 5.7 25.6 ± 4.6 NA - NA NA 28.0 ± 4.8 26. ± 4.2
Female N 21 26 9 9 19 - 21 16 26 29
Female age 54 (40-82) 55 (40-79) 78 (59-86) 55 (26-95) 65 (31-77) - 70 (51-84) 49 (39-59) 73 (35-90) 56 (26-86)
Female BMI 19.9 ± 4.6 24.8 ± 2.2 23 ± 3.2 29 ± 8.0 NA - NA NA 25.5 ± 4.4 24.0 ± 4.5
Stage 0/I 8 - 5 - 10 - 9 - 13 -
Stage II 16 - 8 - 14 - 18 - 21 -
Stage III 15 - 8 - 12 - 11 - 25 -
Stage IV 1 - 2 - 8 - 2 - 7 -
Unknown 0 - 3 - 2 - 0 - 4 -
  1. BMI = body mass index; CRC = colorectal cancer; FTICT-MS = Fourier transform ion cyclotron resonance mass spectroscopy; MRM = multiple reaction monitoring.
\